Sandoz expects the settlement, which is subject to approval from a Pennsylvania federal court, to be finalized before the end of the year. Those involved in the settlement have the right to opt ...

Swiss generic medicines firm Sandoz on Tuesday said it had reached a $275 million settlement with plaintiffs in a legacy US generic drug antitrust lawsuit. Sandoz and subsidiary Fougera ...

Sandoz (SDZNY) announced a number of steps to resolve the US Generic Drug Antitrust Class Action Litigation. Following the previously announced settlements with the US Department of Justice in ...

(RTTNews) - Sandoz Group AG (SDZNY), a Swiss generic and biosimilar medicines maker, announced Tuesday that it has agreed to pay $275 million to the class of end payer plaintiffs to resolve legacy ...

Sandoz US has entered into a settlement agreement with the class of end payer plaintiffs for USD 275 million Provision of USD 265 million taken to cover potential additional settlement costs with ...

Sandoz Group said it would pay $275 million to settle claims from some plaintiffs in a generics drug pricing antitrust lawsuit in the U.S. The Swiss generics-medicine company said Tuesday that it ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Newly independent drugmaker Sandoz has made its first acquisition since spinning out of Novartis last October, buying a brand from Coherus that will boost its position in biosimilar medicines and ...

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

[68] Similar to terazosin, alfuzosin is more effective than finasteride, and an alfuzosin-finasteride combination does not appear to be more effective than alfuzosin alone. Debruyne et al.

Alfuzosin is contraindicated in patients with a hypersensitivity to alfuzosin or other quinazolones. Alfuzosin should be used cautiously in patients who are predisposed to hypotension, including ...